UniPR-1331

N/A

Report date: 2025/03/20 09:19:53
NME

Base Information

Drug NameUniPR-1331
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEphrin type-A receptor 2 antagonists
TargetsEphrin type-A receptor 2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Parma
China Registration ClassN/A

Develop Information

Active CompaniesUniversita Degli Studi Di L'AquilaThe University Of ParmaUniversità Degli Studi Di Brescia
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A